Holberg EEG AS

Based in Norway, Holberg EEG AS specializes in neurodiagnostic solutions, particularly for electroencephalography (EEG) data analysis and reporting through innovative software and AI technologies. Holberg EEG AS, founded in 2009, is headquartered in Bergen, Norway, focusing on enhancing EEG data analysis for healthcare applications. Holberg EEG is a spin-off company from the Haukeland University Hospital. The company has executed a total of 2 deals and was acquired by Natus Medical Incorporated in September 2025 to expand its neurodiagnostic solutions.

Holberg EEG specializes in a suite of innovative products aimed at enhancing the analysis and reporting of electroencephalography (EEG) data. Their core offerings include the hiSCORE software application, which leverages the harmonized standard SCORE to streamline EEG reporting and improve clinical workflows, and the SCORE-AI model, an advanced artificial intelligence system capable of fully automating the assessment of routine clinical EEGs with performance comparable to human experts. The company has built an extensive SCORE database over more than a decade, containing highly annotated EEG recordings that support the development of these products. Their services cater primarily to hospitals, clinics, and academic institutions, facilitating collaboration across multiple sectors within the healthcare industry.

Holberg EEG operates globally, with specific applications expanding into markets in Europe, North America, and select regions in Asia, aiming to integrate wearable technology for personal health monitoring. Holberg EEG generates revenue through a combination of subscription-based models and partnerships with healthcare institutions, leveraging their proprietary technologies. Clients typically enter into agreements for the use of hiSCORE software and SCORE-AI, which are integrated into clinical practices for enhanced EEG reporting and analysis. The transactions may involve tiered subscription plans that provide access to varying levels of features and support, primarily targeting hospitals and research facilities as key customer segments.

Additionally, Holberg EEG engages in collaborative projects with academic and industry partners to further develop their AI tools, which could also contribute to revenue streams through joint ventures or co-development agreements. Their flagship offerings, including the hiSCORE software and the innovative SCORE-AI model, serve as the foundation for their business operations, aligning with the overarching goal of improving clinical efficiency and data utilization within the healthcare sector. Following its acquisition by Natus Medical Incorporated, Holberg EEG AS aims to expand its neurodiagnostic solutions, focusing on the development and launch of new products that enhance EEG analysis capabilities. The company plans to enter new geographic markets, specifically targeting regions in Europe, North America, and select parts of Asia by 2026.

The funding from the acquisition will be utilized to accelerate these initiatives, enhancing product development and market penetration strategies.